InspireMD, Inc.
(NASDAQ : NSPR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.62%612.171.0%$694.47m
DHRDanaher Corp. 0.90%313.520.7%$689.48m
ABTAbbott Laboratories 1.39%126.790.8%$672.08m
MDTMedtronic Plc 1.13%123.020.6%$552.77m
ISRGIntuitive Surgical, Inc. 0.56%341.520.8%$438.08m
ALGNAlign Technology, Inc. -1.49%590.566.3%$335.66m
BDXBecton, Dickinson & Co. 0.28%247.171.0%$300.19m
DXCMDexCom, Inc. -0.27%566.577.8%$274.45m
SYKStryker Corp. -0.19%275.911.3%$272.46m
EWEdwards Lifesciences Corp. 0.76%116.620.4%$266.76m
BSXBoston Scientific Corp. -0.11%44.821.0%$249.23m
AAgilent Technologies, Inc. 0.60%157.881.6%$217.19m
IDXXIDEXX Laboratories, Inc. 1.02%651.853.8%$213.59m
BAXBaxter International, Inc. 0.90%82.191.8%$187.14m
INMDInMode Ltd. 0.64%84.480.0%$180.38m

Company Profile

InspireMD, Inc. operates as a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.